Search

Displaying results 6541 - 6550 of 10000 in total
  1. Drug

    Remeglurant

    go.drugbank.com/drugs/DB21403
    Experimental

    Remeglurant is a small molecule drug. Remeglurant has a monoisotopic molecular weight of 370.04 Da.

  2. Drug

    Sornidipine

    go.drugbank.com/drugs/DB21432
    Experimental

    Sornidipine has a monoisotopic molecular weight of 460.15 Da. … Sornidipine is a small molecule drug. The usage of the INN stem '-dipine' in the name indicates that Sornidipine is a calcium channel blocker, nifedipine derivative.

  3. Drug

    Lm-LLO-TT

    go.drugbank.com/drugs/DB33966
    Experimental

    Lm-LLO-TT is a biologic drug. Lm-LLO-TT is under investigation in clinical trial NCT07828236 (PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA).

  4. Drug

    SRN-101

    go.drugbank.com/drugs/DB33962
    Experimental

    SRN-101 is a biologic drug. … SRN-101 is under investigation in clinical trial NCT07826949 (A Phase 1 Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.).

  5. Drug

    SGX-001

    go.drugbank.com/drugs/DB33968
    Experimental

    SGX-001 is a biologic drug. SGX-001 is under investigation in clinical trial NCT07826767 (Open-label Gene Therapy Study in p47-CGD).

  6. Drug

    BI 4060107

    go.drugbank.com/drugs/DB33963
    Experimental

    BI 4060107 is a small molecule drug. … BI 4060107 is under investigation in clinical trial NCT07827144 (A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)).

  7. Drug

    161Tb-PSMA-1

    go.drugbank.com/drugs/DB33964
    Experimental

    161Tb-PSMA-1 is a small molecule drug. 161Tb-PSMA-1 is under investigation in clinical trial NCT07828249 (Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal

  8. Drug

    JUR-003

    go.drugbank.com/drugs/DB33972
    Experimental

    JUR-003 is a small molecule drug. JUR-003 is under investigation in clinical trial NCT07824349 (JUR-003 in Adult Patients With Metastatic Prostate Cancer).

  9. Drug

    Hydrocortisone

    go.drugbank.com/drugs/DB00741
    ApprovedInvestigationalVet approved

    [A188420] Hydrocortisone was granted FDA approval on 5 August 1952.[L10574] … [L10529,L10532,L10535,L10538,L7772,L7321] It was discovered in the 1930s by Edward Kendall and named Compound F, or 17-hydroxycorticosterone.

    Synonyms: Kendall's compound F, Reichstein's substance MInternational brands: Polcort H, Preparation H Hydrocortisone Cream
  10. Drug

    Modafinil

    go.drugbank.com/drugs/DB00745
    ApprovedInvestigational

    Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. … Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil.

    Categories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 SubstratesSynonyms: 2-((diphenylmethyl)sulfinyl)acetamide